ARCHIVES

Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors.

This article is from The Cancer Letter archive.

Vol. 34 No. 32 | September 5, 2008

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: ONS Biotherapy Phase II, Outcomes-Research Grant

August 3, 2001

In Brief: Mauer Resigns St. Jude Director; Breslow Named DRCCA Board Chairman; Senate Considers Line Items

August 20, 1982

CT Scan Can Spare Surgery In Head And Neck Cancer

November 25, 2005

In Brief: George Vande Woude To Wistar institute Board; Donald Pinkel To Head Pediatric Leukemia Program

October 18, 1985

Chemo, Radiation Improves DFS In Head & Neck Cancer

May 28, 2004

NCCS Networker Volume 8 Issue 1, Spring 1994

April 13, 1994